The anti-cancer agent guttiferone-A permeabilizes mitochondrial membrane: ensuing energetic and oxidative stress

Gilberto L Pardo-Andreu1, Yanier Nuñez-Figueredo, Valeria G Tudella

  • 1Centro de Estudio para las Investigaciones y Evaluaciones Biológicas, Instituto de Farmacia y Alimentos, Universidad de La Habana, Ave. 23 # 21425 e/214 and 222, La Coronela, La Lisa, CP 13600, Ciudad Habana, Cuba. gilbertopardo@infomed.sld.cu

Insights

Guttiferone-A (GA) causes cancer cell death by damaging mitochondria, leading to energy depletion and reactive oxygen species (ROS) production. These mitochondrial effects explain GA's anti-cancer properties.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Guttiferone-A (GA), a natural benzophenone, exhibits cytotoxic and anti-tumor effects.
  • Mitochondria play a crucial role in cellular energy production and apoptosis.

Purpose of the Study:

  • To investigate the role of mitochondria in Guttiferone-A-induced cancer cell toxicity.
  • To elucidate the mechanism of Guttiferone-A action at the mitochondrial level.

Main Methods:

  • Experiments were conducted using hepatic carcinoma (HepG2) cells and isolated rat liver mitochondria.
  • Assessed cellular viability, mitochondrial membrane potential, ATP levels, reactive oxygen species (ROS) production, and mitochondrial membrane permeability.
  • Utilized succinate as an energy substrate and isocitrate for NAD(P)H regeneration.

Main Results:

  • Guttiferone-A decreased HepG2 cell viability, dissipated mitochondrial membrane potential, depleted ATP, and increased ROS.
  • In isolated mitochondria, GA increased membrane fluidity, induced permeabilization, caused uncoupling, and promoted Ca²⁺ efflux, ATP/NAD(P)H depletion, and ROS generation.
  • Isocitrate partially prevented most GA-induced effects, suggesting NAD(P)H's protective role.

Conclusions:

  • Guttiferone-A initiates toxicity by permeabilizing mitochondrial membranes, leading to a cascade of damaging events including potential dissipation, NAD(P)H oxidation, ROS accumulation, and ATP depletion.
  • These mitochondrial disruptions are key to Guttiferone-A's cytotoxic action and potential anti-cancer efficacy.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...